Login to Your Account

India looking at noncommercial use for BMS' dasatinib

By Alfred Romann
Staff Writer

Thursday, May 8, 2014
India is considering waiving a global patent for cancer drug dasatanib under provisions of the country's Patent Act that allow it to make the move for public noncommercial use.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription